BioMed Research International
Volume 2020 (2020), Article ID 2451249, 1 page
https://doi.org/10.1155/2020/2451249

Retraction

Retracted: Apoptosis and Molecular Targeting Therapy in Cancer

BioMed Research International

Received 11 July 2020; Accepted 14 July 2020; Published 30 August 2020

Copyright © 2020. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BioMed Research International has retracted the article titled “Apoptosis and Molecular Targeting Therapy in Cancer” [1]. The article was found to contain a substantial amount of material from previously published articles, including the following sources:

(i) John C Reed. “Apoptosis-targeted therapies for cancer”, Cancer Cell, 2003. 10.1016/S1535-6108(02)00241-6. [2] (Not Cited)

(ii) DB Longley, PG Johnston. “Molecular mechanisms of drug resistance”, The Journal of Pathology, 2005. 10.1002/path.1706. [3] (Not Cited)

(iii) Suparna Mazumder, Dragos Plesca and Alexandru Almasan. “A Jekyll and Hyde Role of Cyclin E in the Genotoxic Stress Response: Switching from Cell Cycle Control to Apoptosis Regulation”, Cell Cycle, 06/15/2007. 10.4161/cc.6.12.4432. [4] (Not Cited)

(iv) Plati, Jessica, Octavian Bucur, and Roya Khosravi-Far. “Apoptotic cell signaling in cancer progression and therapy”, Integrative Biology, 2011. DOI: 10.1039/C0IB00144A. [5] (Not Cited)

(v) C. Gullo, M. Au, G. Feng, and G. Teoh, “The biology of Ku and its potential oncogenic role in cancer,” Biochimica et Biophysica Acta—Reviews on Cancer, vol. 1765, no. 2, pp. 223–234, 2006. 10.1016/j.bbcan.2006.01.001. [6] (Cited as reference 222)

References

M. Hassan, H. Watari, A. AbuAlmaaty, Y. Ohba, and N. Sakuragi, “Apoptosis and Molecular Targeting Therapy in Cancer,” BioMed Research International, vol. 2014, Article ID 150845, 23 pages, 2014.

J. C. Reed, “Apoptosis-targeted therapies for cancer,” Cancer Cell, vol. 3, no. 1, pp. 17–22, 2003.

D. B. Longley and P. G. Johnston, “Molecular Mechanisms of Drug Resistance,” The Journal of Pathology, vol. 205, no. 2, pp. 275–292, 2005.

S. Mazumder, D. Plesca, and A. Almasan, “A Jekyll and Hyde Role of Cyclin E in the Genotoxic Stress Response: Switching from Cell Cycle Control to Apoptosis Regulation,” Cell Cycle, vol. 6, no. 12, pp. 1436–1441, 2007.

J. Plati, O. Bucur, and R. Khosravi-Far, “Apoptotic cell signaling in cancer progression and therapy,” Integrative Biology, vol. 3, no. 4, pp. 279–296, 2011.

C. Gullo, M. Au, G. Feng, and G. Teoh, “The biology of Ku and its potential oncogenic role in cancer,” Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol. 1765, no. 2, pp. 223–234, 2006.